US 8809347
Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
granted A61KA61K31/395A61K31/519
Quick answer
US patent 8809347 (Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/395, A61K31/519, A61P, A61P13/12